Please assess the completion status of the following clinical trial:

Trial Title: Responses of Myocardial Ischemia to Escitalopram Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 21 or greater, less than 90~* Stable ischemic heart disease~Exclusion Criteria:~* Recent myocardial infarction, coronary artery bypass graft surgery, or other revascularization procedures (less than 3 months ago)~* Left ventricular ejection fraction(LVEF) \< 15% measured by echocardiography, radionuclide ventriculography (RNV), or cardiac catheterization~* Life threatening arrhythmia or arrhythmia interrupting the interpretation of ischemia~* Unable to withdraw from anti-anginal medications during ischemic assessment phase~* Unable to perform exercise testing~* Pregnancy~* Current or previous history of bipolar disorder, cyclothymia, schizophrenia, schizoaffective or schizophreniform disorder, or other psychotic disorders~* Active suicidal ideation~* Current substance abuse or history of substance abuse in the previous 6 months~* Significant cardiac, pulmonary, metabolic, renal, hepatic disease, or malignancy, interfering with patient's participation in this study~* Seizure (history and/or present) with/without treatment~* Currently taking antidepressants that cannot be discontinued

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Escitalopram (Type: EXPERIMENTAL): Escitalopram treatment
- Placebo (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).